Cosopt pf and Gabapentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cosopt pf (dorzolamide hydrochloride; timolol maleate) and Gabapentin (gabapentin). Common drug interactions include fatigue among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Cosopt pf and Gabapentin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Cosopt pf?

Cosopt pf has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 1,989 Cosopt pf users. Check the latest studies of Cosopt pf.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

On Jul, 07, 2026

17 people who take Cosopt pf and Gabapentin together, and have interactions are studied.

Cosopt pf and Gabapentin drug interactions.

What are the common drug interactions of Cosopt Pf and Gabapentin, by gender? *:

female:

Fatigue (feeling of tiredness)
Chronic kidney disease
Disease recurrence
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Abdominal pain upper
Bedridden
Blood pressure decreased

male:

Asthenia (weakness)
Diarrhoea
Intraocular pressure increased
Loss of consciousness
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Oedema (fluid collection in tissue)
Oxygen saturation decreased
Pneumonia
Rhinorrhoea (watery mucus discharge from the nose)
Rib fracture

What are the common drug interactions of Cosopt Pf and Gabapentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Disease recurrence
Fatigue (feeling of tiredness)
Flushing (the warm, red condition of human skin)
Haemorrhage intracranial (bleeding within the skull)
Intraocular pressure increased
Lethargy (tiredness)
Loss of consciousness
Malaise (a feeling of general discomfort or uneasiness)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 17.65%
High Blood Cholesterol: 3 people, 17.65%
Prostate Cancer: 2 people, 11.76%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 2 people, 11.76%
Uveitis (inflammation of the uvea): 1 person, 5.88%
Dry Eyes (lack of adequate tears): 1 person, 5.88%
Anaemia (lack of blood): 1 person, 5.88%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 5.88%
Birth Control: 1 person, 5.88%
Blood Phosphorus Decreased: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Cosopt pf and Gabapentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously